BRIEF published on 07/26/2024 at 14:09, 1 month 25 days ago Avemio AG renforce sa stratégie d'achat et de construction par le biais d'acquisitions Acquisition Avemio AG Finance D'entreprise Équité Acheter Et Construire
BRIEF published on 07/26/2024 at 14:09, 1 month 25 days ago Avemio AG Strengthens Buy-and-Build Strategy through Acquisition Acquisition Avemio AG Corporate Finance Equity Buy-and-Build
BRIEF published on 07/26/2024 at 14:06, 1 month 25 days ago Avemio AG acquiert 80 % du capital de LEA Investment GmbH Acquisition Investissement Avemio AG Finance D'entreprise LEA Investment GmbH
BRIEF published on 07/26/2024 at 14:06, 1 month 25 days ago Avemio AG Acquires 80% Stake in L.E.A Investment GmbH Acquisition Investment Avemio AG Corporate Finance L.E.A. Investment GmbH
PRESS RELEASE published on 07/26/2024 at 14:04, 1 month 25 days ago Avemio AG strengthens buy-and-build strategy through acquisition of Corporate Finance Boutique Avemio AG strengthens buy-and-build strategy through acquisition of Corporate Finance Boutique, expanding expertise in financing and M&A activities. Andreas Fischer to lead LEA Group Acquisition Avemio AG Corporate Finance Buy-and-build Strategy Andreas Fischer
PRESS RELEASE published on 07/26/2024 at 14:01, 1 month 25 days ago EQS-Adhoc: Avemio AG: Acquisition of an 80% stake in L.E.A Investment GmbH and its subsidiary Infinment GmbH Avemio AG acquires 80% stake in L.E.A Investment GmbH and Infinment GmbH. Transaction expected to close by 31 August 2024. Purchase price in mid-single-digit million Euro range Acquisition Avemio AG Share Transfer L.E.A Investment GmbH Infinment GmbH
BRIEF published on 07/15/2024 at 10:07, 2 months 5 days ago Avemio AG : Un changement de stratégie et une amélioration de la marge bénéficiaire sont attendus Avemio AG GBC AG BAIIA ACHETER Technologie Des Médias
BRIEF published on 07/15/2024 at 10:07, 2 months 5 days ago Avemio AG: Strategic Shift and Profit Margin Improvement Expected Media Technology EBITDA Avemio AG BUY Rating GBC AG
PRESS RELEASE published on 07/15/2024 at 10:02, 2 months 5 days ago Original-Research: Avemio AG (von GBC AG): BUY Avemio AG reported sales of €99.15 million for 2023 with an expected increase in profit margins. Strategic focus on media technology segment for customer loyalty and earnings quality improvement Media Technology Sales Growth Avemio AG Strategic Focus Profit Margins
PRESS RELEASE published on 07/15/2024 at 10:01, 2 months 5 days ago Original-Research: Avemio AG (von GBC AG): Kaufen Analyse von GBC AG zur Avemio AG: Umsatzrückgang und erwartete Margenverbesserung. Neues Kursziel: 23,00 EUR. Kontinuierliches Umsatzwachstum geplant Avemio AG Kursziel GBC AG Umsatzrückgang Margenverbesserung
Published on 09/20/2024 at 23:40, 2 hours 9 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 2 hours 19 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 2 hours 49 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 3 hours 19 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 3 hours 34 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 2 hours 50 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 4 hours 49 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 5 hours 34 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 5 hours 59 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 6 hours 2 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 8 hours 9 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 8 hours 9 minutes ago Mise à disposition du Rapport Financier Semestriel 2024